The global diabetes care drug market is projected to grow at a CAGR of over 4% during the forecast period. Diabetes is among the major health issues across the globe and it has reached alarming levels. The key factor that drives the growth of the market includes the increasing prevalence of diabetes across the globe. As per the International Diabetes Federation (IDF), around 463 million peoples had diabetes globally in 2019. The global prevalence of diabetes is projected to augment to 578 million by 2030, and 700 million by 2045. It is expected that around 4 million mortalities were observed in 2019 in the age range of 20–79 years;in addition to this, more than one million children and adolescents are living with type 1 diabetes.

A full Report of Global Diabetes Care Drugs Marketis Available at: https://www.omrglobal.com/industry-reports/diabetes-care-drugs-market

As per IDF, the annual global health expenditure on diabetes was around $760 billion in 2019. It is further estimated to reach $825 billion by 2030 and $845 billion by 2045. The expenditure includes consulting services, drugs and device costs, and other additional costs. There are different ways to treat diabetes which include weight loss, healthy eating, regular exercise, diabetes medication, or insulin therapy.Thus, this is likely to enhance the adoption of diabetes care drugs and thereby drives the market growth during the forecast period. However, the availability of alternatives such as diabetes care devices such as insulin pumps and others is projected to hamper market growth during the forecast period.

To learn more about this report request a free sample copy https://www.omrglobal.com/request-sample/diabetes-care-drugs-market

Global Diabetes Care Drugs Market– Segmentation

By Drug Class

• Insulins
• Non-Insulin Injectable Drugs
• Oral Anti-Diabetic Drugs
• Combination Drugs

Regional Analysis

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

Company Profiles

• Astellas Pharma Inc.
• AstraZeneca Plc
• Bayer AG
• Bausch Health Companies Inc.
• Biocon Ltd.
• BoehringerIngelheim International GmbH
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• Generex Biotechnology Corp.
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Midatech Pharma Plc
• Mylan NV
• Novartis International AG
• Novo Nordisk A/S
• Oramed Pharmaceuticals Inc.
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceuticals Co.Ltd.
• Teva Pharmaceuticals Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/diabetes-care-drugs-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404